Department of Radiology and Nuclear Medicine (R.R.M.M.K., C.v.d.L., W.H.v.Z.), Maastricht University Medical Center, the Netherlands.
School for Cardiovascular Diseases Maastricht (CARIM), Maastricht University, the Netherlands (R.R.M.M.K., R.J.v.O., W.H.v.Z.).
Stroke. 2024 Feb;55(2):403-412. doi: 10.1161/STROKEAHA.123.043777. Epub 2024 Jan 4.
The effectiveness of intravenous thrombolysis (IVT) before endovascular treatment (EVT) has been investigated in randomized trials and meta-analyses. These studies mainly concerned anterior circulation occlusions. We aimed to investigate clinical, technical, and safety outcomes of IVT before EVT in posterior circulation occlusions in a nationwide registry.
Patients were included from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), a nationwide, prospective, multicenter registry of patients with acute ischemic stroke due to a large intracranial vessel occlusion receiving EVT between 2014 and 2019. All patients with a posterior circulation occlusion were included. Primary outcome was a shift toward better functional outcome on the modified Rankin Scale at 90 days. Secondary outcomes were favorable functional outcome (modified Rankin Scale scores, 0-3), occurrence of symptomatic intracranial hemorrhages, successful reperfusion (extended Thrombolysis in Cerebral Ischemia ≥2B), first-attempt successful reperfusion, and mortality at 90 days. Regression analyses with adjustments based on univariable analyses and literature were applied.
A total of 248 patients were included, who received either IVT (n=125) or no IVT (n=123) before EVT. Results show no differences in a shift on the modified Rankin Scale (adjusted common odds ratio, 1.04 [95% CI, 0.61-1.76]). Although symptomatic intracranial hemorrhages occurred more often in the IVT group (4.8% versus 2.4%), regression analysis did not show a significant difference (adjusted odds ratio, 1.65 [95% CI, 0.33-8.35]). Successful reperfusion, favorable functional outcome, first-attempt successful reperfusion, and mortality did not differ between patients treated with and without IVT.
We found no significant differences in clinical, technical, and safety outcomes between patients with a large vessel occlusion in the posterior circulation treated with or without IVT before EVT. Our results are in line with the literature on the anterior circulation.
静脉溶栓(IVT)在血管内治疗(EVT)之前的有效性已在随机试验和荟萃分析中进行了研究。这些研究主要涉及前循环闭塞。我们旨在调查全国登记处中后循环闭塞患者接受 EVT 前 IVT 的临床、技术和安全性结局。
该研究纳入了来自 MR CLEAN 登记处(荷兰多中心急性缺血性卒中血管内治疗的随机临床试验)的患者,这是一个全国性的、前瞻性的、多中心登记处,登记了 2014 年至 2019 年间接受 EVT 的因颅内大血管闭塞导致急性缺血性卒中的患者。所有后循环闭塞患者均被纳入。主要结局是 90 天时改良 Rankin 量表(mRS)评分向更好功能结局的转变。次要结局包括良好的功能结局(mRS 评分 0-3)、症状性颅内出血的发生、成功再灌注(扩展脑梗死溶栓评估量表≥2B)、首次尝试再灌注和 90 天时的死亡率。应用基于单变量分析和文献的调整回归分析。
共纳入 248 例患者,其中 125 例患者在 EVT 前接受 IVT,123 例患者未接受 IVT。结果显示,mRS 评分的转变没有差异(调整后的常见优势比,1.04[95%CI,0.61-1.76])。尽管 IVT 组症状性颅内出血的发生率更高(4.8%比 2.4%),但回归分析并未显示显著差异(调整后的优势比,1.65[95%CI,0.33-8.35])。成功再灌注、良好的功能结局、首次尝试再灌注和死亡率在接受和未接受 IVT 的患者之间没有差异。
我们发现,在后循环大血管闭塞患者中,接受和不接受 EVT 前 IVT 治疗的患者在临床、技术和安全性结局方面没有显著差异。我们的结果与前循环的文献一致。